Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS One ; 10(9): e0135515, 2015.
Article in English | MEDLINE | ID: mdl-26340099

ABSTRACT

BACKGROUND: Dietary selenium is of fundamental importance to maintain optimal immune function and enhance immunity during infection. To this end, we examined the effect of selenium on macrophage bactericidal activities against Staphylococcus aureus. METHODS: Assays were performed in golden Syrian hamsters and peritoneal macrophages cultured with S. aureus and different concentrations of selenium. RESULTS: Infected and selenium-supplemented animals have significantly decreased levels of serum nitric oxide (NO) production when compared with infected but non-selenium-supplemented animals at day 7 post-infection (p < 0.05). A low dose of 5 ng/mL selenium induced a significant decrease in macrophage NO production, but significant increase in hydrogen peroxide (H2O2) levels (respectively, p = 0.009, p < 0.001). The NO production and H2O2 levels were significantly increased with increasing concentrations of selenium; the optimal macrophage activity levels were reached at 20 ng/mL. The concentration of 5 ng/mL of selenium induced a significant decrease in the bacterial arginase activity but a significant increase in the macrophage arginase activity. The dose of 20 ng/mL selenium induced a significant decrease of bacterial growth (p < 0.0001) and a significant increase in macrophage phagocytic activity, NO production/arginase balance and S. aureus killing (for all comparisons, p < 0.001). CONCLUSIONS: Selenium acts in a dose-dependent manner on macrophage activation, phagocytosis and bacterial killing suggesting that inadequate doses may cause a loss of macrophage bactericidal activities and that selenium supplementation could enhance the in vivo control of immune response to S. aureus.


Subject(s)
Anti-Bacterial Agents/pharmacology , Macrophage Activation/drug effects , Macrophages, Peritoneal/drug effects , Macrophages, Peritoneal/microbiology , Selenium/pharmacology , Staphylococcal Infections/drug therapy , Staphylococcus aureus/drug effects , Animals , Arginase/immunology , Cells, Cultured , Dietary Supplements/analysis , Macrophages, Peritoneal/immunology , Male , Mesocricetus , Nitric Oxide/immunology , Phagocytosis/drug effects , Staphylococcal Infections/immunology , Staphylococcus aureus/growth & development , Staphylococcus aureus/immunology
2.
J Insect Physiol ; 57(2): 231-45, 2011 Feb.
Article in English | MEDLINE | ID: mdl-21078327

ABSTRACT

Gene silencing through RNA interference (RNAi) has revolutionized the study of gene function, particularly in non-model insects. However, in Lepidoptera (moths and butterflies) RNAi has many times proven to be difficult to achieve. Most of the negative results have been anecdotal and the positive experiments have not been collected in such a way that they are possible to analyze. In this review, we have collected detailed data from more than 150 experiments including all to date published and many unpublished experiments. Despite a large variation in the data, trends that are found are that RNAi is particularly successful in the family Saturniidae and in genes involved in immunity. On the contrary, gene expression in epidermal tissues seems to be most difficult to silence. In addition, gene silencing by feeding dsRNA requires high concentrations for success. Possible causes for the variability of success in RNAi experiments in Lepidoptera are discussed. The review also points to a need to further investigate the mechanism of RNAi in lepidopteran insects and its possible connection to the innate immune response. Our general understanding of RNAi in Lepidoptera will be further aided in the future as our public database at http://insectacentral.org/RNAi will continue to gather information on RNAi experiments.


Subject(s)
Gene Expression Regulation , Lepidoptera/genetics , Lepidoptera/immunology , RNA Interference , Animals , Databases, Genetic , Epidermis/growth & development , Gene Silencing , Immunity, Innate , Insect Proteins/drug effects , Insect Proteins/genetics , Insect Proteins/immunology , Lepidoptera/drug effects , Lepidoptera/growth & development , RNA, Double-Stranded/drug effects , Research Design
3.
Mol Immunol ; 47(14): 2342-8, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20627393

ABSTRACT

Xenorhabdus nematophila/Steinernema carpocapsae and Photorhabdus luminescens/Heterorhabditis bacteriophora are nemato-bacterial complexes highly pathogenic for insects. Using a syringe as artificial vector, we have analyzed the effects of the two bacteria, X. nematophila and P. luminescens on the genetic tool insect, Drosophila melanogaster. Both bacteria were found to kill adult flies in a dose dependent manner with X. nematophila being the fastest. On the other hand, when an injection of non-pathogenic bacteria, Escherichia coli, is performed 1 day before challenge with the entomopathogenic bacteria, then the survival of Drosophila flies was prolonged by at least 20h. After injection of entomopathogenic bacteria, Drosophila mutant Dif(1), affected on the Toll pathway, showed a similar phenotype than wild-type flies whereas Drosophila mutant Dredd(D55), affected on the imd pathway, was not protected by a prior injection of E. coli. This suggested that members of the imd pathway might be targets of these entomopathogenic bacteria albeit synthesis of antimicrobial peptides through this signaling pathway was induced by X. nematophila as well as P. luminescens. Finally, P. luminescens phoP mutant, an avirulent mutant in the Lepidopteran insect, Spodoptera littoralis, was found poorly virulent for D. melanogaster. phoP mutant partially protected D. melanogaster flies if injected 1 day before the injection of P. luminescens wild-type TT01 to the same extent than the E. coli-induced protection. However, phoP recovered a level of pathogenicity comparable to P. luminescens wild-type TT01 when injected to Drosophila flies affected on the imd pathway.


Subject(s)
Drosophila Proteins/immunology , Drosophila melanogaster/immunology , Drosophila melanogaster/microbiology , Photorhabdus/pathogenicity , Xenorhabdus/pathogenicity , Animals , Antimicrobial Cationic Peptides/biosynthesis , Bacterial Proteins/genetics , Base Sequence , Caspases/genetics , Caspases/immunology , DNA Primers/genetics , DNA-Binding Proteins/genetics , DNA-Binding Proteins/immunology , Drosophila Proteins/genetics , Drosophila melanogaster/genetics , Escherichia coli/immunology , Escherichia coli/pathogenicity , Genes, Insect , Mutation , Photorhabdus/genetics , Photorhabdus/immunology , Transcription Factors/genetics , Transcription Factors/immunology , Virulence/genetics , Virulence/immunology , Xenorhabdus/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...